SI-BONE, Inc. revised revenue guidance for the year 2023. The company is increasing its 2023 worldwide revenue guidance to be in the range of $132 million to $134 million from the previous guidance of $128 million to $131 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.04 USD | +0.31% |
|
+4.49% | -37.88% |
07-01 | SI-BONE, Inc.(NasdaqGM:SIBN) added to Russell 3000E Value Index | CI |
05-14 | Transcript : SI-BONE, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.88% | 536M | |
+75.69% | 12.57B | |
-29.47% | 6.82B | |
+5.26% | 5.11B | |
-19.57% | 4.63B | |
+12.15% | 4.04B | |
-24.35% | 3.69B | |
-22.97% | 2.9B | |
-1.86% | 1.94B | |
+12.99% | 1.81B |
- Stock Market
- Equities
- SIBN Stock
- News SI-BONE, Inc.
- SI-BONE, Inc. Revises Revenue Guidance for the Year 2023